American Bio Medica Corporation - ABMC- Profile

American Bio Medica Corporation. The Group's principal activity is to develop, manufacture and market immunoassay diagnostic test kits. It owns two technologies for screening drugs of abuse, a workplace screening test and a preliminary test for use by laboratories. The Group's drugs of abuse screening products offer health care, law enforcement, government, industrial safety and educational professionals, self-contained, one-step screening devices capable of identifying illicit drug use. The products of the Group include Rapid Drug Screen(R), Rapid One(R), Rapid Tec(R), OralStat(R), Drug Detector(TM), Rapid Drug Screen Scan-R(TM) and Rapid Tec Cup(TM). As of January 2005, the Group had thirty three distributors representing 27 countries outside the United States. Develops, manufactures and markets biomedical technologies and products for screening of drugs